Morgan Stanley on ProLogis (PLD): 'We believe the key to the guidance cut is the drop in the company's net absorption guidance'
Tweet Send to a Friend
Morgan Stanley analyst Ronald Kamdem reiterated an Overweight rating and $141.00 price target on ProLogis (NYSE: PLD)The analyst comments "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
